Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
6,453,052
-
Share change
-
+1,268,443
-
Total reported value
-
$319,499,983
-
Put/Call ratio
-
673%
-
Price per share
-
$49.51
-
Number of holders
-
151
-
Value change
-
+$59,803,632
-
Number of buys
-
91
-
Number of sells
-
60
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2017
As of 31 Mar 2017,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,453,052 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GLENMEDE TRUST CO NA, STATE STREET CORP, FIRST MANHATTAN CO, RENAISSANCE TECHNOLOGIES LLC, PERCEPTIVE ADVISORS LLC, NOMURA HOLDINGS INC, BANK OF AMERICA CORP /DE/, and DIMENSIONAL FUND ADVISORS LP.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.